Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2008American Journal of HematologyOpen Access

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJelena M. KaoStanford UniversityAMAlex McMillanUniversity of BristolPGPeter L. GreenbergUniversity of California, San Francisco

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kao et al. (2008) studied this question.

synapsesocial.com/papers/6a8504c7d476d8de6f0cc138https://doi.org/10.1002/ajh.21249
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathophysiology of anaemia: focus on the heart and blood vessels2000 · 375 citations
  2. 2Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes2007 · 1,039 citations
  3. 3Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making2005 · 865 citations
  4. 4Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion2006 · 1,329 citations
  5. 5New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients2007 · 798 citations